Innovation in hematology. Perspectives: CML 2016

di Hehlmann, Rüdiger
Pubblicato in Haematologica (2016)

Research in the heart of hematology: chronic myeloid leukemia 2017

di Hehlmann, Rüdiger
Pubblicato in Haematologica (2017)

Chronic Myeloid Leukemia in 2020

di Hehlmann, Rüdiger
Pubblicato in Hemasphere (2020)

The New ELN Recommendations for Treating CML

di Hehlmann, Rüdiger
Pubblicato in J Clin Med (2020)

Genomic Instability in Context of the Chromosomal Theory

di Fabarius, Alice, Duesberg, Peter, Giehl, Michelle, Seifarth, Wolfgang, Hochhaus, Andreas, Hehlmann, Rüdiger
Pubblicato in Cell Oncol (2008)

Human Endogenous Retrovirus Expression Profiles in Samples from Brains of Patients with Schizophrenia and Bipolar Disorders

di Frank, Oliver, Giehl, Michelle, Zheng, Chun, Hehlmann, Rüdiger, Leib-Mösch, Christine, Seifarth, Wolfgang
Pubblicazione 2005

Rolf Neth (October 6, 1926 to March 17, 2020)

di Hehlmann, Rüdiger, Gallo, Robert, Hoelzer, Dieter, Welte, Karl, Gale, Robert Peter, Zander, Axel
Pubblicato in Leukemia (2020)

Adhesion to fibronectin stimulates proliferation of wild-type and bcr/abl-transfected murine hematopoietic cells

di Krämer, Alwin, Hörner, Susanne, Willer, Andreas, Fruehauf, Stefan, Hochhaus, Andreas, Hallek, Michael, Hehlmann, Rüdiger
Pubblicazione 1999

Specific Detection of Aspergillus Species in Blood and Bronchoalveolar Lavage Samples of Immunocompromised Patients by Two-Step PCR

di Skladny, Heyko, Buchheidt, Dieter, Baust, Corinna, Krieg-Schneider, Frank, Seifarth, Wolfgang, Leib-Mösch, Christine, Hehlmann, Rüdiger
Pubblicazione 1999

Comprehensive Analysis of Human Endogenous Retrovirus Transcriptional Activity in Human Tissues with a Retrovirus-Specific Microarray

di Seifarth, Wolfgang, Frank, Oliver, Zeilfelder, Udo, Spiess, Birgit, Greenwood, Alex D., Hehlmann, Rüdiger, Leib-Mösch, Christine
Pubblicazione 2005

Variable Transcriptional Activity of Endogenous Retroviruses in Human Breast Cancer

di Frank, Oliver, Verbeke, Caroline, Schwarz, Norbert, Mayer, Jens, Fabarius, Alice, Hehlmann, Rüdiger, Leib-Mösch, Christine, Seifarth, Wolfgang
Pubblicazione 2008

DNA Microarray-Based Detection and Identification of Fungal Pathogens in Clinical Samples from Neutropenic Patients

di Spiess, Birgit, Seifarth, Wolfgang, Hummel, Margit, Frank, Oliver, Fabarius, Alice, Zheng, Chun, Mörz, Handan, Hehlmann, Rüdiger, Buchheidt, Dieter
Pubblicazione 2007

Development of a LightCycler PCR Assay for Detection and Quantification of Aspergillus fumigatus DNA in Clinical Samples from Neutropenic Patients

di Spiess, Birgit, Buchheidt, Dieter, Baust, Corinna, Skladny, Heyko, Seifarth, Wolfgang, Zeilfelder, Udo, Leib-Mösch, Christine, Mörz, Handan, Hehlmann, Rüdiger
Pubblicazione 2003

Proviral Structure, Chromosomal Location, and Expression of HERV-K-T47D, a Novel Human Endogenous Retrovirus Derived from T47D Particles

di Seifarth, Wolfgang, Baust, Corinna, Murr, Andreas, Skladny, Heyko, Krieg-Schneider, Frank, Blusch, Jürgen, Werner, Thomas, Hehlmann, Rüdiger, Leib-Mösch, Christine
Pubblicazione 1998

A polymorphism associated with STAT3 expression and response of chronic myeloid leukemia to interferon α

di Kreil, Sebastian, Waghorn, Katherine, Ernst, Thomas, Chase, Andrew, White, Helen, Hehlmann, Rüdiger, Reiter, Andreas, Hochhaus, Andreas, Cross, Nicholas C.P.
Pubblicazione 2010

Dynamics of mutant BCR-ABL-positive clones after cessation of tyrosine kinase inhibitor therapy

di Hanfstein, Benjamin, Müller, Martin C., Kreil, Sebastian, Ernst, Thomas, Schenk, Thomas, Lorentz, Christian, Schwindel, Uwe, Leitner, Armin, Hehlmann, Rüdiger, Hochhaus, Andreas
Pubblicazione 2011

Treatment patterns and clinical outcomes of tyrosine kinase inhibitors in chronic‐phase CML in clinical practice: 3‐year European SIMPLICITY data

di Gambacorti‐Passerini, Carlo, Chen, Clara, Davis, Catherine, Sen, Ginny P., Guyan, Christy, Hehlmann, Rüdiger, Michallet, Mauricette, Paquette, Ronald, Goldberg, Stuart L.
Pubblicato in Eur J Haematol (2020)

Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States

di Padula, William V., Larson, Richard A., Dusetzina, Stacie B., Apperley, Jane F., Hehlmann, Rudiger, Baccarani, Michele, Eigendorff, Ekkehard, Guilhot, Joelle, Guilhot, Francois, Hehlmann, Rudiger, Mahon, Francois-Xavier, Martinelli, Giovanni, Mayer, Jiri, Müller, Martin C., Niederwieser, Dietger, Saussele, Susanne, Schiffer, Charles A., Silver, Richard T., Simonsson, Bengt, Conti, Rena M.
Pubblicato in J Natl Cancer Inst (2016)

Clonal Evolution and Blast Crisis Correlate with Enhanced Proteolytic Activity of Separase in BCR-ABL b3a2 Fusion Type CML under Imatinib Therapy

di Haaß, Wiltrud, Kleiner, Helga, Weiß, Christel, Haferlach, Claudia, Schlegelberger, Brigitte, Müller, Martin C., Hehlmann, Rüdiger, Hofmann, Wolf-Karsten, Fabarius, Alice, Seifarth, Wolfgang
Pubblicato in PLoS One (2015)

Contemporary insights into the pathogenesis and treatment of chronic myeloproliferative neoplasms

di Mughal, Tariq I., Abdel-Wahab, Omar, Rampal, Raajit, Mesa, Ruben, Koschmieder, Steffen, Levine, Ross, Hehlmann, Rüdiger, Saglio, Giuseppe, Barbui, Tiziano, Van Etten, Richard A.
Pubblicato in Leuk Lymphoma (2016)